Skip to content
Home/Companies/Biotech/Endodiag
EN

Endodiag

Biotech·France·Active·9yr hold

Endodiag is a healthcare company, headquartered in France.

Entry
2017
Hold
9yr
Status
Active
Est. EV
–

Who owns Endodiag?

Endodiag is currently owned by Karista through CapDecisif 3 (2013 vintage), since 2017. Across its history, Endodiag has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Karista
Most recent investor
Karista
CapDecisif 3 · 2013 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthcare

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Crédit Mutuel Equity and Karista since 2017.
Co-invest · 2 holders · 2017 · present
Crédit Mutuel Equity
Crédit Mutuel EquityActive
2017 · present · Crédit Mutuel Equity · 1992 · Growth
MOIC
–
Karista
KaristaActive
2017 · present · CapDecisif 3 · 2013 · VC
MOIC
–

More from CapDecisif 3

Other portfolio companies in the same fund.

PayinTech
Active
FinancialsFrance· 2017
PulseSight Therapeutics
Exited 2019
HealthcareFrance· 2017
to
Actvt
Active
SoftwareFrance· 2016
E(ye)Brain
Active
HealthcareFrance· 2016
Minka Therapeutics
Exited 2022
HealthcareFrance· 2016
to
Nexdot
Active
Deep TechFrance· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings